Los Angeles, California – An outbreak of drug-resistant bacteria linked to several eye drop brands has led to four deaths and multiple cases of blindness, according to recent announcements by the Food and Drug Administration. The Centers for Disease Control and Prevention reported that 14 people have lost their vision, with four individuals needing their eyeballs removed. Across 18 states, 81 patients have been infected with the bacteria Pseudomonas aeruginosa as of May 15.
Many consumers rely on nonprescription, over-the-counter eye drops for dryness, irritation, and other eye conditions. However, the recent recalls of various eye drop brands have raised concerns among regular users about the safety of these products.
Global Pharma Healthcare issued a recall of EzriCare and Delsam Pharma brands of “Artificial Tears Lubricant Eye Drops” due to potential bacterial contamination. The recall was prompted by 55 reports of adverse reactions, including eye infections and vision loss. Consumers were warned that using the contaminated eye drops could result in blindness.
In a separate recall, Global Pharma Healthcare recalled a batch of Delsam Pharma “Artificial Eye Ointment” over concerns of microbial contamination. Apotex also recalled six lots of its “Brimonidine Tartrate Ophthalmic Solution, 0.15%” due to sterility issues, while Pharmedica USA recalled two lots of “Purely Soothing, 15% MSM Drops” for similar concerns.
The outbreak of drug-resistant Pseudomonas aeruginosa was first detected in a patient in Los Angeles County in 2022, leading to subsequent cases in multiple states. The CDC linked the infections to the use of artificial tears, with 81 patients across 18 states affected. Health officials highlighted the risks associated with using contaminated eye drops, urging patients to stop using the recalled products immediately.
Patients who have used the recalled eye drops and experience symptoms such as eye discharge, pain, redness, or blurry vision are advised to seek medical attention promptly. The CDC and FDA emphasize the importance of discontinuing the use of recalled eye drops, even if no adverse reactions have occurred.
Dr. David Agus, a medical contributor, warned consumers to stick to reputable brands and consider whether they truly need to use eye drops. He emphasized the importance of consulting with an eye doctor before using such products. The FDA and CDC continue to monitor the situation and provide updates on the outbreak.